Evans David W 4
4 · Guardion Health Sciences, Inc. · Filed Oct 30, 2019
Insider Transaction Report
Form 4
Evans David W
Director10% Owner
Transactions
- Award
Common Stock
2019-10-30$0.33/sh+2,000$664→ 1,544,500 total - Award
Warrant
2019-10-30$0.01/sh+2,000$20→ 2,000 totalExercise: $0.34Exp: 2024-10-30→ Common Stock (2,000 underlying)
Footnotes (1)
- [F1]Reporting Person purchased 2,000 Series B warrants in Issuer's follow-on public offering, which closed on October 30, 2019, which warrant will become exercisable only after the Issuer effectuates an amendment to its Charter to either (i) increase the number of authorized shares of common stock or (ii) implement a reverse stock split with respect to the shares of common stock. The Series B warrants will then be exercisable any time up to the date that is five years after the Charter Amendment is effectuated.